Skip to main content
SpringerLink
Log in

Therapy with interleukin-2 induces the systemic release of phospholipase-A2

  • Original Article
  • Interleukin-2, Interleukin-6, Tumour Necrosis Factor, Phospholipase A2, Cancer
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Abstract

Therapy with interleukin-2 (IL-2) induces remissions in some forms of cancer. This treatment however, is accompanied by side-effects which, in part, may be mediated by the formation of eicosanoids and plateletactivating factor. We investigated the systemic release of phospholipase A2 (PLA2), a rate-limiting enzyme in the formation of these lipid mediators, in patients receiving IL-2. In a pilot study of 4 patients we observed an increase in PLA2 activity in serial plasma samples obtained during the first day after a bolus infusion of IL-2, which increase closely correlated with that of antigen levels of secretory phospholipase A2 (sPLA2) as measured by enzyme-linked immunosorbent assay (r=0.92;P<0.001). In 20 patients, receiving 12×106−18×106 IU IL-2/m2, we then investigated the course of antigenic levels of sPLA2 in relation to those of the cytokines tumour necrosis factor α (TNF) and interleukin-6 (IL-6) (both cytokines may induce sPLA2 in vivo). From 4 h on, sPLA2 levels significantly increased, reaching a peak 24 h after the IL-2 infusion. Subsequent IL-2 infusions even induced a further increase of sPLA2. This increase of sPLA2 was presumably not due to a direct effect of IL-2 on, for example, hepatocytes, since this cytokine, in contrast to IL-1, IL-6, TNF and interferon γ, was not able to induce the synthesis of sPLA2 by Hep G2 cells in vitro. Consistent with this, plasma levels of TNF and IL-6 in the patients rose, reaching peak levels before a zenith of sPLA2 occurred, i.e at 2 h and 4 h after the start of the IL-2 infusion respectively. sPLA2 levels significantly correlated with the development of the side-effects increase in body weight (r=0.49;P<0.0001) and decrease in mean arterial blood pressure (r=0.40;P<0.0001). Moreover, maximum sPLA2 levels induced by IL-2 were higher in patients who had progressive disease after therapy than in patients who had stable disease or a partial response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Baars JW, De Boer JP, Wagstaff J, Roem D, Eerenberg AJM, Nauta J, Pinedo HM, Hack CE (1992) Interleukin-2 induces activation of coagulation and fibrinolysis: resemblance to the changes seen during experimental endotoxaemia. Br J haematol 82: 295

    PubMed  Google Scholar 

  2. Baars JW, Hack CE, Wagstaff J, Eerenberg-Belmer AJM, Wolbink GJ, Thijs LG, Strack van Schijndel RJM, Van der Vall HLJA, Pinedo HM (1992) The activation of polymorphonuclear neutrophils and the complement system during immunotherapy with recombinant interleukin-2, Br J Cancer 65: 96

    PubMed  Google Scholar 

  3. Barbour SE, Dennis EA (1993) Antisense inhibition of group II phospholipase A2 expression blocks the production of prostaglandin E2 by P338D1 cells. J Biol Chem 268: 21875

    PubMed  Google Scholar 

  4. Boccoli G, Masciulli R, Ruggeri EM, Carlini P, Giannella G, Montesoro E, Mastroberardino G, Isacchi G, Testa U, Calabresi F, Peschle C (1990) Adoptive immunotherapy of human cancer: The cytokine cascade and monocyte activation following high-dose interleukin 2 bolus treatment. Cancer Res 50: 5795

    PubMed  Google Scholar 

  5. Cirino G, Cicala C, Sorrentino L, Maiello FM, Browning JL (1994) Recombinant secreted nonpancreatic phospholipase A2 induces a synovitis-like inflammation in rat air pouch. J Rheumatol 21: 824

    PubMed  Google Scholar 

  6. Crowl RM, Stoller JT, Conroy RR, Stoner CR (1991) Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response. J Biol Chem 226: 2647

    Google Scholar 

  7. Fattal E, Nir S, Parente RA, Szoka Jr FC (1994) Pore-forming peptides induce rapid phospholipid flip-flop in membranes. Biochemistry 33: 6721

    PubMed  Google Scholar 

  8. Ferro JT, Jonson A, Everitt J, Malik AB (1989) Il-2 induces pulmonary oedema and vasoconstriction independent of circulating lymphocytes. J Immunol 142: 1916

    PubMed  Google Scholar 

  9. Gaynor ER, Vitek L, Sticklin L, Creekmore SP, Ferraro ME, Thomas JX, Fisher SG, Fisher RI (1988) The hemodynamic effects of treatment with interleukin-2 and lymphokine activated killer cells. Ann Intern Med 109: 953

    PubMed  Google Scholar 

  10. Giulia Salgo M, Corongiu FP, Sevanian A (1992) Peroxidation and phospholipase A2 hydrolytic susceptibility of liposomes consisting of mixed species of phosphatidylcholine and phosphatidylethanolamine, Biochim Biophys Acta 1127: 131

    PubMed  Google Scholar 

  11. Hack CE, Nuijens JH, Felt-Bersma RJF, Schreuder WO, Eerenberg-Belmer AJM, Paardekooper J, Bronsveld W, Thijs LG (1989) Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis. Am J Med 86: 20

    PubMed  Google Scholar 

  12. Helle M, Boeije L, De Groot ER, De Vos A, Arden LA (1991) Sensitive ELISA for interleukin 6. Detection of IL-6 in biological fluids: synovial fluids and sera. J Immunol Methods 138: 47

    PubMed  Google Scholar 

  13. Hibbs, JB, Westenfelder C, Taintor R, Vavrin Z, Kablitz C, Baranowski RL, Ward JH, Menlove RL, Mcmurry MP, Kushner JP, Samlowski WE (1992) Evidence for cytokine-inducible nitric oxide synthesis from 1-arginine in patients receiving interleukin-2 therapy. J Clin Invest 89: 867

    PubMed  Google Scholar 

  14. Hidi R, Vargaftig BB, Touqui L (1993) Increased synthesis and secretion of a 14-kDa phospholipase A2 by guinea pig alveolar macrophages, J Immunol 151: 5613

    PubMed  Google Scholar 

  15. Kellermann W, Frentzel-Beyme R, Welte M, Jochum M (1989) Phospholipase A in acute lung injury after trauma and sepsis: its relation to the inflammatory mediators PMN-elastase, C3a and neopterin, Klin Wochenschr 67: 190

    PubMed  Google Scholar 

  16. Morgan DW, Anderson GM, Meyers KP (1993) Recombinant human type phospholipase A2 lacks edema producing activity in rat. Eur J Pharmacol 235: 45

    PubMed  Google Scholar 

  17. Murakami M, Hara N, Kudo I, Inoue K (1993) Triggering of degranulation in mast cells by exogenous type II phospholipase A2, J Immunol 151: 5675

    PubMed  Google Scholar 

  18. Nevalainen TJ (1993) Serum phospholipases A2 in inflammatory diseases, Clin Chem 39: 2453

    PubMed  Google Scholar 

  19. Ognibene FP, Rosenberg SA, Lotze M, Skibber J, Parker MM, Shelhamer JH, Parillo JE (1988) Interleukin-2 administration causes reversible hemodynamic changes and left ventricular dysfunction similar to those seen in septic shock. Chest 94: 750

    PubMed  Google Scholar 

  20. Pfeilschifter J, Schalkwijk C, Briner VA, Van den Bosch H (1993) Cytokine-stimulated secretion of group II phospholipase A2 by rat mesangial cells. Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells. J Clin Invest 92: 2516

    PubMed  Google Scholar 

  21. Pruzanski W, Vadas P (1991) Phospholipase A2 — a mediator between proximal and distal effectors of inflammation. Immunol Today 12: 143

    PubMed  Google Scholar 

  22. Rabinovici R, Sofronski MD, Renz JF, Hillegas LM, Esser KM, Vernick J, Feuerstein G (1992) Platelet activating factor mediates interleukin-2-induced lung injury in the rat. J Clin Invest 89: 1669

    PubMed  Google Scholar 

  23. Ransac S, Aarsman AJ, Van den Bosch H, Gancet C, De Haas GH, Verger R (1992) Rat platelet phospholipase A2. Kinetic characterization using the monomolecular film technique. Eur J Biochem 204: 793

    PubMed  Google Scholar 

  24. Rintala EM, Nevalainen TJ (1993) Synovial-type (group II) phospholipase A2 in serum of febrile patients with heamatological malignancy. Eur J Haematol 50: 11

    PubMed  Google Scholar 

  25. Rosenberg SA, Lotze MT, Muul LM, Chang AE, Avis FP, Leitman S, Marston Lineman W, Robertson CN, Lee RA, Rubin JT, Seipp C, Simpson CG, White DE (1987) A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med 316: 889

    PubMed  Google Scholar 

  26. Sagone AL, Husney RM, Triozzi PL, Rinehart J (1991) Interleukin-2 therapy enhances salicylate oxidation of blood granulocytes. Blood 78: 2931

    PubMed  Google Scholar 

  27. Santos AA, Browning JL, Scheltinga MR, Lynch EA, Brown EF, Lawton MS, Chambers MA, Dougas I, Benjamin CD, Dinarello CA, Wolff SM, Jacobs DO, Wilmore DW (1994) Are events after endotoxemia related to circulating phospholipase A2, Ann Surg 219: 183

    PubMed  Google Scholar 

  28. Smith GM, Ward RL, McGuigan L, Rajkovic IA, Scott KF (1992) Measurement of human phospholipase A2 in arthritis plasma using a newly developed sandwich ELISA. Br J Rheumatol 31: 175

    PubMed  Google Scholar 

  29. Vadas P, Pruzanski W (1993) Induction of group II phospholipase A2 expression and pathogenesis of the sepsis syndrome. Circ Shock 39: 160

    PubMed  Google Scholar 

  30. Vadas P, Schouten BD, Stefanski E, Scott K, Pruzanski W (1993) Association of hyperphospholipasemia A2 with multiple system organ dysfunction due to salicylate intoxication. Crit Care Med 21: 1087

    PubMed  Google Scholar 

  31. Van den Bosch H, Aarsman AJ (1979) A review on methods of phospholipase A determination, Agents Actions 9: 382

    PubMed  Google Scholar 

  32. Van den Bosch H, Aarsman AJ, Van Deenen LLM (1974) Isolation and properties of a phospholipase A1 activity from bovine pancreas. Biochim Biophys Acta 348: 197

    PubMed  Google Scholar 

  33. Welbourn R, Goldman G, Kobzik L, Valeri CR, Shepro D, Hechtman HB (1990) Involvement of thromboxane and neutrophils in multiple-system organ oedema with interleukine-2. Ann Surg 212: 728

    PubMed  Google Scholar 

  34. Simpson WG, Heys SD, Whiting PH, Eremin O, Broom J (1995) Acute phase proteins and recombinant IL-2 therapy: prediction of response and survival in patients with colorectal cancer. Clin Exp Immunol 99: 143

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands

    Gert Jan Wolbink & C. Erik Hack

  2. Laboratory for Clinical and Experimental Immunology, University of Amsterdam, Amsterdam, The Netherlands

    Gert Jan Wolbink & C. Erik Hack

  3. Centre for Biomembranes and Lipid Enzymology, University of Utrecht, Utrecht, The Netherlands

    Caspar Schalkwijk & Henk van den Bosch

  4. Department of Oncology, Free University Hospital, Amsterdam, The Netherlands

    Joke W. Baars & John Wagstaff

  5. Department of Internal Medicine, Free University Hospital, Amsterdam, The Netherlands

    C. Erik Hack

Authors
  1. Gert Jan Wolbink
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Caspar Schalkwijk
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joke W. Baars
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John Wagstaff
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Henk van den Bosch
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C. Erik Hack
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wolbink, G.J., Schalkwijk, C., Baars, J.W. et al. Therapy with interleukin-2 induces the systemic release of phospholipase-A2 . Cancer Immunol Immunother 41, 287–292 (1995). https://doi.org/10.1007/BF01517216

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01517216

Key words

Search

Navigation